                         SEQUENCE LISTING

<110>  MUSC Foundation for Research Development
       Feghali-Bostwick, Carol
 
<120>  Endostatin Peptides for Treating Tumors, Fibrosis and Acute Lung Injury

<130>  206085-0035-00WO

<140>  PCT/US20/40627
<141>  2020-07-02

<150>  US 62/872,301
<151>  2019-07-10

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-terminal endostatin-derived peptide 96

<400>  1

Ala Thr Gly Gln Ala Ser Ser Leu Leu 
1               5                   


<210>  2
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-terminal endostatin-derived peptide E4-03

<400>  2

Ser Tyr Cys Glu Thr Trp Arg Thr Glu Ala Pro Ser Ala Thr Gly Gln 
1               5                   10                  15      


Ala Ser Ser Leu Leu Gly Gly Arg Leu Leu Gly Gln Ser Ala Ala Ser 
            20                  25                  30          


Cys His His Ala 
        35      


<210>  3
<211>  48
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-terminal endostatin-derived peptide E4

<400>  3

Ser Tyr Cys Glu Thr Trp Arg Thr Glu Ala Pro Ser Ala Thr Gly Gln 
1               5                   10                  15      


Ala Ser Ser Leu Leu Gly Gly Arg Leu Leu Gly Gln Ser Ala Ala Ser 
            20                  25                  30          


Cys His His Ala Tyr Ile Val Leu Cys Ile Glu Asn Ser Phe Met Thr 
        35                  40                  45              


<210>  4
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-terminal endostatin-derived peptide 96-17

<400>  4

Ala Thr Gly Gln Ala Ser Ser Leu Leu Gly Gly Arg Leu Leu Gly Gln 
1               5                   10                  15      


Ser Ala Ala Ser Cys His His Ala 
            20                  


<210>  5
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-terminal endostatin-derived peptide 96-87

<400>  5

Ala Thr Gly Gln Ala Ser Ser Leu Leu Gly Gly Arg Leu Leu Gly Gln 
1               5                   10                  15      


<210>  6
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-terminal endostatin-derived peptide 91-96

<400>  6

Ser Tyr Cys Glu Thr Trp Arg Thr Glu Ala Pro Ser Ala Thr Gly Gln 
1               5                   10                  15      


Ala Ser Ser Leu Leu 
            20      


<210>  7
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-terminal endostatin-derived peptide 91-97

<400>  7

Ser Tyr Cys Glu Thr Trp Arg Thr Glu Ala Pro Ser Ala Thr Gly Gln 
1               5                   10                  15      


Ala Ser Ser Leu Leu Gly Gly Arg Leu Leu Gly Gln 
            20                  25              

